Published in J Neurosci Res on March 01, 1992
AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am J Pathol (1995) 1.06
Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci U S A (1997) 0.96
GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation. J Immunol (2011) 0.86
Corticosteroid use in neuro-oncology: an update. Neurooncol Pract (2014) 0.77
Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology (1985) 4.11
Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci (1996) 2.61
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol (2001) 2.39
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (2005) 2.09
Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature (1981) 2.06
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet (2002) 2.01
Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med (1990) 1.99
Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet (1988) 1.97
PCV chemotherapy for recurrent glioblastoma multiforme. Neurology (2001) 1.80
Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci (1992) 1.79
Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol (1993) 1.79
Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol (1994) 1.75
Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients. AJR Am J Roentgenol (1992) 1.68
Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res (1998) 1.67
Paclitaxel-induced neuropathy. Ann Oncol (1995) 1.65
Do corticosteroids damage the brain? J Neuroendocrinol (2006) 1.64
Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci (1984) 1.61
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 1.56
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 1.51
A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol (2001) 1.51
The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol (1995) 1.49
Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol (2000) 1.44
Thermal discrimination thresholds in normal subjects and in patients with diabetic neuropathy. J Neurol Neurosurg Psychiatry (1985) 1.43
MicroSAGE: a modified procedure for serial analysis of gene expression in limited amounts of tissue. Nucleic Acids Res (1999) 1.42
Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg (2000) 1.41
[Stereotaxic irradiation of vestibular schwannoma (acoustic neuroma)]. Ned Tijdschr Geneeskd (2000) 1.40
Expression profile of 30,000 genes in rat hippocampus using SAGE. Hippocampus (2001) 1.39
Cerebellar and medullar histoplasmosis. Neurology (2000) 1.39
[Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants]. Ned Tijdschr Geneeskd (2004) 1.38
[Multidisciplinary treatment of cerebral arteriovenous malformations: preliminary results in 115 consecutive patients]. Ned Tijdschr Geneeskd (1997) 1.38
Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol (1994) 1.37
Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology (2003) 1.35
Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys (2000) 1.34
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol (2001) 1.33
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol (2001) 1.32
Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology (2001) 1.32
Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci (1993) 1.31
The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology (2003) 1.31
Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol (2002) 1.31
Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology (1998) 1.30
Control of neuronal excitability by corticosteroid hormones. Trends Neurosci (1992) 1.29
Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther (1988) 1.29
Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol (1998) 1.29
Maternal deprivation effect on the infant's neural stress markers is reversed by tactile stimulation and feeding but not by suppressing corticosterone. J Neurosci (1998) 1.28
Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci U S A (2001) 1.27
Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci (2001) 1.27
Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science (1989) 1.26
Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. J Cell Sci (1995) 1.26
Stress, glucocorticoids and development. Prog Brain Res (1988) 1.24
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord (2001) 1.23
The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome. Psychoneuroendocrinology (2013) 1.22
The postnatal development of the hypothalamic-pituitary-adrenal axis in the mouse. Int J Dev Neurosci (2003) 1.22
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med (1998) 1.22
Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol (1998) 1.21
Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur J Neurosci (1998) 1.18
Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors. Eur J Neurosci (2008) 1.16
Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J Neuroendocrinol (2006) 1.16
Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res (1993) 1.15
Genetic selection for coping style predicts stressor susceptibility. J Neuroendocrinol (2003) 1.14
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group. Neurology (1998) 1.13
Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology (1996) 1.13
9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. Eur J Pharmacol (1987) 1.13
Hypophyseal non-Hodgkin's lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy. J Neurooncol (1993) 1.13
Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J Steroid Biochem (1986) 1.11
On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology (1989) 1.11
Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology (2002) 1.11
The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer (2004) 1.10
Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med (1997) 1.10
Large and small nerve fiber function in painful diabetic neuropathy. J Neurol Sci (1986) 1.10
Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers. Nat Neurosci (2000) 1.10
The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur J Neurosci (1994) 1.08
Estradiol modulates density of putative 'oxytocin receptors' in discrete rat brain regions. Neuroendocrinology (1986) 1.08
Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol (1987) 1.08
Paclitaxel (Taxol) concentrations in brain tumor tissue. Ann Oncol (1994) 1.07
Late neurocognitive sequelae in patients with WHO grade I meningioma. J Neurol Neurosurg Psychiatry (2008) 1.06
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med (1998) 1.06
The dynamics of the hypothalamic-pituitary-adrenal axis during maternal deprivation. J Neuroendocrinol (2004) 1.05
Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase. Eur J Pharmacol (1977) 1.05
Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus. J Neurosci Res (1997) 1.04
Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem Res (1997) 1.04
Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med (1997) 1.04
Corticosteroids and the brain. J Steroid Biochem Mol Biol (1990) 1.03
Spinal subarachnoid hemorrhage due to a filum terminale ependymoma. Clin Neurol Neurosurg (1992) 1.03
Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology (2004) 1.01
Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood (1998) 1.01
Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior. Mol Psychiatry (2012) 1.01
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys. Mov Disord (1994) 1.01
Stress responsiveness varies over the ultradian glucocorticoid cycle in a brain-region-specific manner. Endocrinology (2010) 1.01
Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene. Endocrinology (2007) 1.00
Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. J Neurol (1998) 1.00
The use of various animal models in the study of stress and stress-related phenomena. Lab Anim (1994) 1.00
Effect of penicillin on transmitter release from rat cortical tissue. Brain Res (1980) 1.00
Dopamine D2 receptor stimulation differentially affects voltage-activated calcium channels in rat pituitary melanotropic cells. J Physiol (1992) 1.00
Long-term effects of vincristine on the peripheral nervous system. J Neurooncol (1993) 1.00
Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology (2012) 0.99
Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology (2005) 0.98